Richard Sloan Moon, MD in Florence, TX - Family Medicine

Richard Sloan Moon, MD is a Family Medicine physician based in Florence, Texas. Richard Sloan Moon is licensed to practice in Texas (license number E-6531) and his current practice location is 202 W Caskey, Florence, Texas. He can be reached at his office (for appointments etc.) via phone at (254) 793-2240.

NPI number for Richard Sloan Moon is 1043797723 and his current mailing address is Pobox 505, 202 W Caskey, Florence, Texas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1043797723.

Contact Information

	Richard Sloan Moon, MD
	202 W Caskey, Florence, TX 76527
	(254) 793-2240
	Not Available

Physician's Profile

Full Name	Richard Sloan Moon
Gender	Male
Speciality	Family Medicine
Location	202 W Caskey, Florence, Texas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1043797723
Provider Enumeration Date: 07/25/2018
Last Update Date: 07/25/2018

Medical Identifiers

Medical identifiers for Richard Sloan Moon such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043797723	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	E-6531 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Richard Sloan Moon is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Richard Sloan Moon, MD Pobox 505, 202 W Caskey, Florence, TX 76527 Ph: (254) 793-2240	Richard Sloan Moon, MD 202 W Caskey, Florence, TX 76527 Ph: (254) 793-2240

News Archive

Substantial equivalence review requirement for new tobacco products announced

The U.S. Food and Drug Administration announced today that certain tobacco products introduced or changed after Feb. 15, 2007 must be reviewed by the agency. In FDA guidance published today, the agency outlines a pathway for marketing a product whereby the company marketing the product must prove that it is "substantially equivalent" to products commercially available on Feb. 15, 2007.

Study evaluates COVID-19's impact on food-shopping behavior for food-insecure populations

The COVID-19 pandemic changed just about every aspect of normal life, including how we bought food.

Angiocidin reduces acute myeloid leukemia cells in vivo by almost two-thirds in pre-clinical studies

Angiocidin, a novel tumor-inhibiting protein, has been shown to reduce acute myeloid leukemia (AML) cells in vivo by almost two-thirds in pre-clinical experiments.

Indonesia reluctant when it comes to sharing bird flu samples

Indonesia, the country with the highest number of human deaths from the bird flu, remains reluctant to share samples of live bird flu virus for research.

Hospitals turn to luxury services to entice patients

Hospitals around the country are seeking to attract more paying customers with high-end services while at the same time find ways to cut down expenses from patients who cannot pay their bills.

Richard Sloan Moon, MD - Family Medicine in Florence, TX